Legal & General Group PLC Finch Therapeutics Group, Inc. Transaction History

Legal & General Group PLC

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2022 Aug 22, 2022	SELL	$1.91 - $5.11 $1,151 - $3,081	-603 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$12.03 - $17.51 $7,254 - $10,558	603 New	603 $8,000

Ticker FNCH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,688,400
Market Cap $572M
Description
Finch Therapeutics Group, Inc., a clinical-stage microbiome therapeutics company, develops a novel class of orally administered biological drugs in the United States. The company's lead candidate is CP101, an orally administered microbiome capsule that is in Phase 3 clinical trial for the treatment of patients with recurrent Clostridioides diffi...

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

Stay updated on Legal & General Group PLC with notifications on news.